Patents by Inventor Rolf Servin

Rolf Servin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8951502
    Abstract: The invention relates to a method of dynamic nuclear polarisation (DNP) using a combination of a trityl radical and a paramagnetic metal ion as the polarising agent leading to enhanced levels of polarisation in the sample to be polarised and to compositions and polarising agents for use in the method.
    Type: Grant
    Filed: December 1, 2006
    Date of Patent: February 10, 2015
    Assignee: GE Healthcare AS
    Inventors: Mikkel Thaning, Rolf Servin
  • Patent number: 8273874
    Abstract: The invention relates to an improved method of dynamic nuclear polarisation (DNP) of carboxylic acids and to compounds and compositions for use in the method.
    Type: Grant
    Filed: August 29, 2007
    Date of Patent: September 25, 2012
    Assignee: GE Healthcare AS
    Inventors: Christian Gloegaard, Rolf Servin, Mikkel Thaning
  • Patent number: 8003077
    Abstract: The present invention relates to a method for the production of hyperpolarized 129Xe and to a method for the production of a contrast agent.
    Type: Grant
    Filed: October 24, 2003
    Date of Patent: August 23, 2011
    Assignee: GE Healthcare AS
    Inventors: Jan-Henrik Ardenkjaer-Larsen, Lennart Hansson, Haukur Johannesson, Rolf Servin, Lars-Goran Wistrand
  • Publication number: 20100190967
    Abstract: The invention relates to an improved method of dynamic nuclear polarisation (DNP) of carboxylic acids and to compounds and compositions for use in the method.
    Type: Application
    Filed: August 29, 2007
    Publication date: July 29, 2010
    Inventors: Christian Gloegaard, Rolf Servin, Mikkel Thaning
  • Patent number: 7557573
    Abstract: The invention relates to NMR-based methods comprising hyperpolarised ligands or targets for use in NMR-based assays.
    Type: Grant
    Filed: November 27, 2003
    Date of Patent: July 7, 2009
    Assignee: GE Healthcare AS
    Inventors: Jan-Henrik Ardenkjaer-Larsen, Herbert Baumann, Graham John Cotton, Klaes Golman, Mark Howard, Mathilde H. Lerche, Rolf Servin, Mikkel Thaning, Jan Wolber
  • Patent number: 7550970
    Abstract: The present invention relates to methods of performing Nuclear Magnetic Resonance (NMR) spectroscopy adapted for a hyperpolarized sample. The methods comprise the steps of hyperpolarizing a sample using DNP, wherein at least a portion of the NMR active nuclei receives hyperpolarization; performing NMR spectroscopy on the sample with the use of sequences of rf-pulses, wherein the pulse sequences comprises at least two rf-pulses, either on the same nuclei or on different nuclei, and wherein the pulse sequence is adapted for a hyperpolarized sample; and analyzing at least two of the NMR spectra to obtain a characterization of the sample, or to obtain an interim result to be used in the NMR spectroscopy step.
    Type: Grant
    Filed: April 13, 2004
    Date of Patent: June 23, 2009
    Assignee: GE Healthcare AS
    Inventors: Rolf Servin, Jan Henrik Ardenkjaer-Larsen, Haukur Johannesson, Maurice Goldman, Jan Wolber
  • Publication number: 20080260649
    Abstract: The invention relates to a method of dynamic nuclear polarisation (DNP) using a combination of a trityl radical and a paramagnetic metal ion as the polarising agent leading to enhanced levels of polarisation in the sample to be polarised and to compositions and polarising agents for use in the method.
    Type: Application
    Filed: December 1, 2006
    Publication date: October 23, 2008
    Inventors: Mikkel Thaning, Rolf Servin
  • Patent number: 7372274
    Abstract: The present invention relates to devices and method for dissolving solid polarised material while retaining a high level of polarisation. In an embodiment of the present invention a material is polarised in a strong magnetic field in a cryostat 2 and then brought into solution while still inside the cryostat 2.
    Type: Grant
    Filed: November 2, 2001
    Date of Patent: May 13, 2008
    Assignee: GE Healthcare AS
    Inventors: Jan Henrik Ardenkjaer-Larsen, Oskar H. E. Axelsson, Klaes Koppel Golman, Georg Hansson, Haukur Johannesson, Rolf Servin, Mikkel Thaning, Lennart Hansson
  • Publication number: 20080061781
    Abstract: The present invention relates to methods of performing Nuclear Magnetic Resonance (NMR) spectroscopy adapted for a hyperpolarized sample. The methods comprise the steps of hyperpolarizing a sample using DNP, wherein at least a portion of the NMR active nuclei receives hyperpolarization; performing NMR spectroscopy on the sample with the use of sequences of rf-pulses, wherein the pulse sequences comprises at least two rf-pulses, either on the same nuclei or on different nuclei, and wherein the pulse sequence is adapted for a hyperpolarized sample; and analysing at least two of the NMR spectra to obtain a characterization of the sample, or to obtain an interim result to be used in the NMR spectroscopy step.
    Type: Application
    Filed: April 13, 2004
    Publication date: March 13, 2008
    Inventors: Rolf Servin, Jan Henrik Ardenkjaer-Larsen, Haukur Johannesson, Maurice Goldman, Jan Wolber
  • Publication number: 20060173282
    Abstract: The present invention relates to a method for the production of hyperpolarized 129Xe and to a method for the production of a contrast agent.
    Type: Application
    Filed: October 24, 2003
    Publication date: August 3, 2006
    Inventors: Jan-Henrik Ardenkjaer-Larsen, Lennart Hansson, Haukur Johannesson, Rolf Servin, Lars-Goran Wistrand
  • Publication number: 20060171891
    Abstract: The invention relates to NMR-based methods comprising hyperpolarised ligands or targets for use in NMR-based assays.
    Type: Application
    Filed: November 27, 2003
    Publication date: August 3, 2006
    Inventors: Jan-Henrik Ardenkjaer-Larsen, Herbert Baumann, Graham Cotton, Klaes Golman, Mark Howard, Mathilde Lerche, Rolf Servin, Mikkel Thaning, Jan Wolber
  • Publication number: 20050233470
    Abstract: The invention relates to methods for determining protein activity using NMR spectroscopy. The present invention provides a method for determining protein activity in vivo using probe compounds and enhancing the nuclear polarisation of NMR active nuclei present in the probe compounds (hereinafter termed “hyperpolarisation”) prior to NMR analysis. The invention also provides mixtures of probe compounds for the above-mentioned method.
    Type: Application
    Filed: April 15, 2003
    Publication date: October 20, 2005
    Inventors: Bill Clark, Klaes Golman, Mathilde Lerche, Mike Looker, Mike O'Sullivan, Albie Santos, Rolf Servin, Mikkel Thaning, Jan-Henrik Ardenkjaer-Larsen
  • Publication number: 20050232864
    Abstract: The invention relates to methods for phenotyping by determining protein activity in vivo using at least one probe compound and enhancing the nuclear polarisation of NMR active nuclei present in the probe compound (hereinafter termed “hyperpolarisation”) prior to NMR analysis.
    Type: Application
    Filed: April 15, 2003
    Publication date: October 20, 2005
    Inventors: Bill Clark, Klaes Golman, Mathilde Lerche, Mike Looker, Mike O'Sullivan, Albie Santos, Rolf Servin, Mikkel Thaning, Jan-Henrik Ardenkjaer-Larsen
  • Publication number: 20040066193
    Abstract: The present invention relates to devices and method for dissolving solid polarised material while retaining a high level of polarisation. In an embodiment of the present invention a material is polarised in a strong magnetic field in a cryostat 2 and then brought into solution while still inside the cryostat 2.
    Type: Application
    Filed: August 29, 2003
    Publication date: April 8, 2004
    Inventors: Jan Henrik Ardenkjaer-Larsen, Oskar H.E. Axelsson, Klaes Koppel Golman, Georg Hansson, H. Johannesson, Rolf Servin, Mikkel Thaning, Lennart Hansson
  • Publication number: 20040049108
    Abstract: The present invention relates to devices and method for melting solid polarised sample while retaining a high level of polarisation. In an embodiment of the present invention a sample is polarised in a sample-retaining cup (9) in a strong magnetic field in a polarising means (3a, 3b, 3c) in a cryostat (2) and then melted inside the cryostat (2) by melting means such as a laser (8) connected by an optical fibre (4) to the interior of the cryostat.
    Type: Application
    Filed: August 29, 2003
    Publication date: March 11, 2004
    Inventors: Jan Henrik Ardenkjaer-Larsen, Oskar H.E. Axelsson, Klaes Koppel Golman, Georg Hansson, H. Johannesson, Rolf Servin, Mikkel Thaning, Lennart Hansson
  • Patent number: 6063360
    Abstract: The present invention relates to certain novel triaryl methyl free radicals and their use as image enhancing agents in magnetic resonance imaging (MRI) as well as to contrast media containing such radicals and to the use of such radicals and their non-radical precursors in the manufacture of MRI contrast media.
    Type: Grant
    Filed: March 6, 1998
    Date of Patent: May 16, 2000
    Assignee: Nycomed Imaging A/S
    Inventors: Sven Andersson, Finn Radner, Anna Rydbeck, Rolf Servin, Lars-Goran Wistrand, Mikkel Thaning
  • Patent number: 5827501
    Abstract: The present invention relates to a method of generating an electron spin resonance enhanced magnetic resonance image of a sample which comprises introducing into the sample a magnetic resonance signal enhancing amount of a free radical and generating an enhanced electron spin resonance image of the sample. The method comprises using as the free radical an inert triarylmethyl free radical, wherein each aryl moiety of said triarylmethyl radical, which may be identical or different, comprises an optionally substituted 6-membered carbocyclic or thienyl ring. The invention also relates to the use of trityls in ESR imaging.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: October 27, 1998
    Assignee: Nycomed Imaging AS
    Inventors: Mikkel J.o slashed.rgensen, Frode Rise, Sven Andersson, Torsten Almen, Arne Aabye, Lars-Goran Wistrand, H.ang.kan Wikstrom, Klaes Golman, Rolf Servin, Peter Michelsen
  • Patent number: 5728370
    Abstract: The present invention relates to certain novel triaryl methyl free radicals and their use as image enhancing agents in magnetic resonance imaging (MRI) as well as to contrast media containing such radicals and to the use of such radicals and their non-radical precursors in the manufacture of MRI contrast media.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: March 17, 1998
    Assignee: Nycomed Imaging AS
    Inventors: Sven Andersson, Finn Radner, Anna Rydbeck, Rolf Servin, Lars-Goran Wistrand
  • Patent number: 5530140
    Abstract: The invention provides novel persistent free radicals useful in Overhauser MRI being triarylmethyl radicals having as at least one aryl group a group of formula ##STR1## (wherein each X which may be the same or different is an oxygen or sulphur atom or a group CO or S(O).sub.n, (where n is 1 to 3) with the proviso that at least one group X is a sulphur atom or a S(O).sub.n group; R.sup.1 is a hydrogen atom or group of formula --M, --XM, --X--Ar.sup.2, or --Ar.sup.2 where M is a water solubilizing group, and Ar.sup.2 represents a 5-10 membered aromatic ring optionally substituted by a water solubilizing group M; and each of the groups R.sup.7, which may be the same or different, is a hydrogen atom, or a hydrocarbon group or a water solubilizing group M, or two groups R.sup.
    Type: Grant
    Filed: March 31, 1994
    Date of Patent: June 25, 1996
    Assignee: Nycomed Imaging AS
    Inventors: Sven Andersson, Finn Radner, Anna Rydbeek, Rolf Servin, Lars-Goran Wistrand